It has been reported that miR-320a is poorly expressed in patients with myasthenia gravis and regulates the inflammatory cytokines production through targeting mitogen-activated protein kinase 1 (Cheng et al., 2013). Here, MAP2K1 is linked to myasthenia gravis.